Clinical acceptability of monophasic gestodene

Area of Science:

• Reproductive Health
• Pharmacology
• Clinical Trials

Background:

• Monophasic oral contraceptives are widely used for birth control.
• Assessing long-term safety and efficacy is crucial for widespread adoption.

Purpose of the Study:

• To evaluate the contraceptive reliability of a 30mcg ethinyl estradiol/75mcg gestodene formulation.
• To assess cycle control, metabolic effects, and concomitant symptoms.
• To gather real-world data through post-marketing surveillance.

Main Methods:

• Analysis of clinical data from Phase III and Phase IV studies.
• Inclusion of data from 600,000 therapy cycles involving 100,000 women.
• Longitudinal observation with some participants followed for up to 3 years.

Main Results:

• High contraceptive reliability demonstrated.
• Excellent cycle control observed in users.
• The gestodene combination was well-tolerated with a low frequency of concomitant symptoms.
• Low drop-out rates indicate user satisfaction and adherence.

Conclusions:

• The monophasic oral contraceptive containing ethinyl estradiol and gestodene meets essential criteria for effective birth control.
• The formulation offers a reliable and well-tolerated option for women.
• Extensive clinical data support its safety and efficacy profile.